Mechanisms of Disease: temozolomide and glioblastoma—look to the future
Nature Clinical Practice Oncology · 2008-08 · 5 (8) · 476-486
DOI: 10.1038/ncponc1155 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nature Clinical Practice Oncology, online erschienen am 10.06.2008. Verfasst von Maciej M Mrugala und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, Washington 98106, USA. Die Arbeit wurde bisher 144-mal zitiert (Crossref) und nennt 79 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, Washington 98106, USA.
Zitieren
APA
Mrugala, M. M., & Chamberlain, M. C. (2008). Mechanisms of Disease: temozolomide and glioblastoma—look to the future. Nature Clinical Practice Oncology, 5(8), 476-486. https://doi.org/10.1038/ncponc1155
Vancouver
Mrugala MM, Chamberlain MC. Mechanisms of Disease: temozolomide and glioblastoma—look to the future. Nature Clinical Practice Oncology. 2008;5(8):476-486. doi:10.1038/ncponc1155
BibTeX
@article{Mrugala2008,
author = {Mrugala, Maciej M and Chamberlain, Marc C},
title = {Mechanisms of Disease: temozolomide and glioblastoma—look to the future},
journal = {Nature Clinical Practice Oncology},
year = {2008},
volume = {5},
number = {8},
pages = {476--486},
doi = {10.1038/ncponc1155}
}
EUVIMED